News & Updates
Filter by Specialty:
Adjunctive semaglutide yields additional weight loss in teens with obesity
Once-weekly treatment with semaglutide, when administered with lifestyle intervention, leads to greater reduction in body mass index among adolescents with obesity as compared with lifestyle intervention alone, as shown in the STEP TEENS study.
Adjunctive semaglutide yields additional weight loss in teens with obesity
16 Nov 2022
COVID-19 vaccine for children below 5 years: most parents still hesitant
Widespread hesitancy around COVID-19 vaccination in children below 5 years does exist, even among parents showing preference for vaccinating their child in this age group, a US study suggests.
COVID-19 vaccine for children below 5 years: most parents still hesitant
10 Nov 2022
Two-drug dolutegravir-based regimen a valid alternative for pregnant women with HIV
For pregnant women with HIV who are receiving dolutegravir (DTG)-based therapies, the two-drug regimen works just as well as three-drug regimens at keeping the viral load to "undetectable" levels without exerting serious adverse effects on neonatal outcomes, according to a study presented at HIV Glasgow 2022 Congress.
Two-drug dolutegravir-based regimen a valid alternative for pregnant women with HIV
07 Nov 2022
Foetoplacental factors predict hypertension in early childhood
Foetal growth deceleration and high foetoplacental vascular resistance both contribute to an increased risk of prehypertension and hypertension in children, a study has found.
